Melanoma Clinical Trials

Showing 701-720 of 1,477 trials

Fast Track Diagnosis of Skin Cancer by Advanced Imaging Technologies and Tumour Tapestripping

NCT05389085

In this clinical feasibility study the investigators will test and compare two advanced optical imaging technologies, lipid and RNA tape stripping with regards to diagnostic accuracies for fast bedside diagnosis of pigmented skin tumours.

Skin CancerMalignant Melanoma

University Hospital Bispebjerg and Frederiksberg75 participantsStarted May 2022

Copenhagen, Denmark

TERMINATED

Healthcare Resource Utilization and Costs in Metastatic Melanoma Patients Initiated Dabrafenib + Trametinib and Encorafenib + Binimetinib

NCT05848219

This was a retrospective cohort study using the MarketScan health care administrative claim databases: Truven Health Analytics' MarketScan Commercial Claims and Encounters; MarketScan Medicare Supplement and Coordination of Benefit. We conducted this analysis using the most recent available data from the MarketScan database at the time of analysis, which was 01 June 2018 to 31 December 2020. We initiated this analysis from 01 June 2018 as encorafenib + binimetinib (enco/bini) was approved for patients with unresectable or metastatic melanoma with BRAF mutation at this time.

Metastatic Melanoma

Novartis Pharmaceuticals543 participantsStarted Oct 2021

East Hanover, New Jersey, United States

COMPLETEDNA

Imaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its Precursors

NCT05842421

Prospective, unicentric study that examines if imaging devices like total body photography, dermoscopy, optical coherence tomography and in vivo reflectance confocal microscopy as an addition to clinical examination lead to a benefit for patients in the diagnosis of non-melanoma skin cancer and their precursors

Non-melanoma Skin Cancer

Technische Universität Dresden250 participantsStarted Apr 2021

Dresden, Saxony, Germany

Fast Track Diagnosis of Skin Cancer by Advanced Imaging Technologies and Tumour Tapestripping

Healthcare Resource Utilization and Costs in Metastatic Melanoma Patients Initiated Dabrafenib + Trametinib and Encorafenib + Binimetinib

Imaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its Precursors

Related Searches

Safety Study of SEA-CD40 in Cancer Patients

KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma

Bangladesh Vitamin E and Selenium Trial

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma

Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma

Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma

Patient Characteristics, Associated Factors, and Clinical Outcomes of Prescribing Encorafenib and Binimetenib Versus Dabrafenib and Trametinib Among BRAF v600 Mutated Metastatic Melanoma Patients

Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial

Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Study of Temzolomide and Gleevec in Advanced Melanoma

PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor

Optical Frequency Domain Imaging for Non-melanoma Skin Cancers

(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma

The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery

Immunological Variables Associated to ICI Toxicity in Cancer Patients